Live Breaking News & Updates on Tarsus Pharmaceuticals Inc|Page 17

Stay updated with breaking news from Tarsus pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Guggenheim Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $49.00

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective hoisted by equities researchers at Guggenheim from $46.00 to $49.00 in a report released on Monday, MarketBeat Ratings reports. The firm currently has a “buy” rating on the stock. Guggenheim’s target price indicates a potential upside of 198.23% from the stock’s previous close. Several […] ....

United States , William Blair , Bobakr Azamian , Blackrock Inc , Securities Exchange Commission , Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Company Profile , Tarsus Pharmaceuticals Inc , News Ratings For Tarsus Pharmaceuticals Daily , Vanguard Group Inc , Tarsus Pharmaceuticals Stock Down , Institutional Investors Weigh In On Tarsus Pharmaceuticals , Jefferies Financial Group Inc , Get Free Report , Marketbeat Ratings , Pharmaceuticals Stock Down , Exchange Commission , Financial Group , Exoduspoint Capital Management , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Boost Price Target ,

Contrasting Rubius Therapeutics (NASDAQ:RUBY) and Tarsus Pharmaceuticals (NASDAQ:TARS)

Contrasting Rubius Therapeutics (NASDAQ:RUBY) and Tarsus Pharmaceuticals (NASDAQ:TARS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Tarsus Pharmaceuticals , Rubius Therapeutics Inc , Tarsus Pharmaceuticals Inc , Rubius Therapeutics , Get Free Report , Tarsus Pharmaceutical , Given Tarsus Pharmaceutical , Rubius Therapeutics Daily ,

Tarsus to Present at Upcoming Investor Conferences

Tarsus to Present at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Bobak Azamian , Adrienne Kemp , Jeff Farrow , David Nakasone , Morgan Stanley , Corporate Communications , Tarsus Pharmaceuticals Inc , Chief Executive Officer , Chief Financial , Strategy Officer , New York City , Annual Global Investment Conference , Fireside Chat , Annual Global Healthcare Conference , Tarsus Pharmaceuticals , Meibomian Gland Disease ,

15 Most Shorted Stocks That Are Loved By Analysts

In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts. If you want to skip our introduction to short selling, then jump ahead to 5 Most Shorted Stocks That Are Loved By Analysts. Short selling is a tricky game. Rapid share price appreciations can stretch a […] ....

United States , Paul Marshall , Albert Cha , Frank Kung Vivo , Henrik Rhenman , Tarsus Pharmaceuticals Inc , Ken Griffin Citadel Investment Group , Pliant Therapeutics Inc , Therapeutics Inc , Ardelyx Inc , Jp Morgan , Bionano Genomics Inc , Ebix Inc , Biovie Inc , Aldeyra Therapeutics Inc , Microvast Holdings Inc , Ian Wace Marshall , Inmune Bio Inc , Cantor Fitzgerald , Drug Administration , Dyne Therapeutics Inc , Lovesac Company , Marga Santoso , Wall Street , Strong Buy , Shorted Stocks That Are Loved ,